Peng-Chan Lin

736 total citations
30 papers, 540 citations indexed

About

Peng-Chan Lin is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Peng-Chan Lin has authored 30 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Peng-Chan Lin's work include Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Treatment and Pharmacology (6 papers). Peng-Chan Lin is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Treatment and Pharmacology (6 papers). Peng-Chan Lin collaborates with scholars based in Taiwan, United States and Germany. Peng-Chan Lin's co-authors include Chung-Ta Lee, Nan-Haw Chow, Po‐Min Chen, Shao-Chieh Lin, Tzeon-Jye Chiou, Liang-Tsai Hsiao, Ming-Yang Lee, Yu-Min Yeh, Ta‐Chung Chao and Meng‐Ru Shen and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Peng-Chan Lin

30 papers receiving 533 citations

Peers

Countries citing papers authored by Peng-Chan Lin

Since Specialization

Citations

This map shows the geographic impact of Peng-Chan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng-Chan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng-Chan Lin more than expected).

Fields of papers citing papers by Peng-Chan Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng-Chan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng-Chan Lin. The network helps show where Peng-Chan Lin may publish in the future.

Co-authorship network of co-authors of Peng-Chan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Peng-Chan Lin. A scholar is included among the top collaborators of Peng-Chan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng-Chan Lin. Peng-Chan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The multinomial mixed-effect regression model for predicting PCOC phases in hospice patients 2024 ·Supportive Care in Cancer ·(unknown), (unknown), Peng-Chan Lin, Pei‐Fang Su, (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer 2021 ·Frontiers in Oncology ·(unknown), Peng-Chan Lin, Shang‐Hung Chen, Shao-Chieh Lin, (unknown), Bo‐Wen Lin, Meng‐Ru Shen, Yu-Min Yeh	9
3	Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy 2021 ·BMC Cancer ·Peng-Chan Lin, Yu-Min Yeh, (unknown), Bo‐Wen Lin, (unknown), (unknown), Meng‐Ru Shen	11
4	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer 2019 ·Scientific Reports ·Peng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, Keng‐Fu Hsu, Jang‐Yang Chang, Meng‐Ru Shen	13
5	Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment 2019 ·PLoS ONE ·Jason C. Hsu, (unknown), Peng-Chan Lin, (unknown)	14
6	MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway 2019 ·EBioMedicine ·(unknown), Chung-Ta Lee, Jenq-Chang Lee, Yi-Wen Wang, (unknown), Sheng‐Hui Lan, Peng-Chan Lin, Bo‐Wen Lin, Yu-Feng Tian, Hsiao‐Sheng Liu, Nan-Haw Chow	52
7	Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan 2018 ·PLoS ONE ·Jason C. Hsu, (unknown), (unknown), Peng-Chan Lin	14
8	Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway 2018 ·Oncogene ·Po‐Chen Chu, Peng-Chan Lin, (unknown), Kuen‐Tyng Lin, Christina Wu, Tanios Bekaii‐Saab, Yih-Jyh Lin, Chung-Ta Lee, (unknown), Ching-Shih Chen	46
9	The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages 2017 ·Clinical Cancer Research ·Yu-Min Yeh, (unknown), Peng-Chan Lin, Keng‐Fu Hsu, Pei-Ying Wu, Wu‐Chou Su, Jang‐Yang Chang, Meng‐Ru Shen	18
10	Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients 2014 ·Quality of Life Research ·Hong‐Hwa Chen, William Tzu-Liang Chen, (unknown), Jen-Kou Lin, (unknown), (unknown), Peng-Chan Lin, Bo-Wen Lin, Chi-Chou Huang, (unknown), Hsi-Hsien Hsu, Hung‐Chang Chen, (unknown), Ming‐Chin Yang, Elise Chia‐Hui Tan	5
11	Characterization of a colorectal cancer migration and autophagy-related microRNA miR-338-5p and its target gene PIK3C3 2013 ·(unknown), (unknown), Sheng‐Hui Lan, (unknown), Peng-Chan Lin, (unknown), Yu-Feng Tian, Hsiao‐Sheng Liu	18
12	Dynamic Change of Tetraspanin CD151 Membrane Protein Expression in Colorectal Cancer Patients 2011 ·Cancer Investigation ·Peng-Chan Lin, Shao-Chieh Lin, Chung-Ta Lee, Yih-Jyh Lin, Jenq-Chang Lee	9
13	The Prognostic Significance of RON and MET Receptor Coexpression in Patients with Colorectal Cancer 2008 ·Diseases of the Colon & Rectum ·Chung-Ta Lee, Nan-Haw Chow, Pei-Fang Su, Shao-Chieh Lin, Peng-Chan Lin, (unknown)	59
14	Virus reactivation in high-risk non-Hodgkin’s lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation 2008 ·International Journal of Hematology ·Peng-Chan Lin, Ming-Yang Lee, (unknown), Liang-Tsai Hsiao, Po‐Min Chen, Tzeon-Jye Chiou	5
15	Comparison of Myeloablative and Nonmyeloablative Hematopoietic Stem Cell Transplantation for Treatment of Chronic Myeloid Leukemia 2007 ·International Journal of Hematology ·Ming‐Huang Chen, Tzeon-Jye Chiou, Peng-Chan Lin, Jyh-Pyng Gau, Hui-Chi Hsu, Liang-Tsai Hsiao, Liu H, Po‐Min Chen	7
16	N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data 2006 ·Supportive Care in Cancer ·Peng-Chan Lin, Ming-Yang Lee, Wei-Shu Wang, Chueh‐Chuan Yen, Ta‐Chung Chao, Liang-Tsai Hsiao, Muh‐Hwa Yang, Po‐Min Chen, Kon-Ping Lin, Tzeon-Jye Chiou	89
17	Sequential Therapy with Capecitabine Followed by Vinorelbine/Cisplatin in Patients with Anthracycline/Taxane-refractory Metastatic Breast Cancer 2006 ·Journal of the Chinese Medical Association ·Peng-Chan Lin, Wei-Shu Wang, Muh‐Hwa Yang, Chueh‐Chuan Yen, Ta‐Chung Chao, Liang-Tsai Hsiao, Po‐Min Chen	3
18	High Prevalence of SV40 Infection in Patients with Nodal Non-Hodgkin's Lymphoma But Not Acute Leukemia Independent of Contaminated Polio Vaccines in Taiwan 2006 ·Cancer Investigation ·Po‐Min Chen, Chueh‐Chuan Yen, Muh‐Hwa Yang, (unknown), Liang-Tsai Hsiao, Wei-Shu Wang, Peng-Chan Lin, Ming-Yang Lee, Hao‐Wei Teng, (unknown), (unknown), (unknown), An-Hang Yang, Tzeon-Jye Chiou, Liu H, Ta‐Chung Chao	8
19	Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer 2006 ·Cancer Chemotherapy and Pharmacology ·Peng-Chan Lin, Wei-Shone Chen, Ta‐Chung Chao, Shung-Haur Yang, Chui-Mei Tiu, Liu H	15
20	Fatal Fulminant Hepatitis B after Withdrawal of Prophylactic Lamivudine in Hematopoietic Stem Cell Transplantation Patients 2005 ·International Journal of Hematology ·Peng-Chan Lin, (unknown), Ming-Yang Lee, Liang-Tsai Hsiao, Po‐Min Chen, Tzeon-Jye Chiou	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact